ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE by Teva is avandamet: avandamet combines 2 antidiabetic agents with different mechanisms of action to improve glycemic control in patients with type 2 diabetes: rosiglitazone, a member of the thiazolidinedione class, and metformin, a member of the biguanide class. First approved in 2014.
Drug data last refreshed 20h ago
AVANDAMET: AVANDAMET combines 2 antidiabetic agents with different mechanisms of action to improve glycemic control in patients with type 2 diabetes: Rosiglitazone, a member of the thiazolidinedione class, and metformin, a member of the biguanide class. Thiazolidinediones are insulin sensitizing…
Worked on ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.